Table 1 Exosomal miRNAs isolated from body fluids of cancer patients as potential biomarkers

Lung cancer

Plasma

miR-151a-5p, miR-30a-3p, miR-200b-5p, miR-629, miR-100, miR-154-3p

[26]

Plasma

let-7f, miR-30e-3p, miR-223, miR-301

[27]

Plasma

miR-17-3p, miR-21, miR-106a, miR-146, miR-155 miR-191, miR-192, miR-203, miR-205, miR-210, miR-212, miR-214

[28]

Nasopharyngeal carcinoma

Serum

miR-24-3p, miR-891a, miR-106a-5p, miR-20a-5p, miR-1908

[29]

Esophageal

Serum

miR-21

[30]

squamous cell carcinoma

Serum

miR-1246

[31]

Breast cancer

Serum

miR-200a, miR-200c, miR-205

[32]

Serum

miR-21

[33]

Serum

miR-101, 372, 373

[34]

Hepatocellular carcinoma

Serum

miR-21

[35]

Pancreatic cancer

Serum

miR-17-5p, miR-21

[36]

Serum

miR-1246, miR-4644, miR-3976, miR-4306

[37]

Prostate cancer

Plasma, Serum,

miR-107, miR-141, miR-375, miR-574-3p

[38]

Urine, Serum

miR-141

[39]

Glioblastoma

Serum

miR-320, miR-574-3p

[40]

Cerebrospinal fluid

miR-21

[41]

Colorectal cancer

Serum

Let-7a, miR-1229, miR-1246, miR-150, miR-21, miR-223, miR-23a

[42]

Serum

miR-17-92a cluster

[43]

Ovarian cancer

Serum

miR-21, miR-141, miR-200a, miR-200b, miR-200c, miR-203, miR-205, miR-214

[44]

Cervical cancer

Cervicovaginal lavage

miR-21, miR-146a

[45]